HIV

Integrase inhibitors give greater chance of viral suppression in pregnant women

Posted on , updated on by Health Reporter

  Integrase inhibitors give greater chance of viral suppression at delivery in pregnant women   Jump to Raltegravir-based ART started in pregnancy Dolutegravir-based ART started in late pregnancy References Integrase inhibitor-based treatment with either raltegravir (Isentress) or dolutegravir (Tivicay, also in Triumeq) reduces viral load more rapidly than efavirenz if started in pregnancy, findings from two randomised […]

HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption

Posted on , updated on by Health Reporter

HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in the Journal of Infectious Diseases last week. The case report underlines the importance of participants […]

Transgender women taking PrEP have lower levels of PrEP drugs, especially in rectal tissues, than cisgender men

Posted on , updated on by Health Reporter

Craig Hendrix at HIVR4P 2018. Photo by Roger Pebody. Gus Cairns Published: 09 November 2018 Difference “equivalent to four days of PrEP per week rather than seven” A study presented at last month’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis […]

US doctors’ organization endorses event-based PrEP for the first time

Posted on , updated on by Health Reporter

US doctors’ organization endorses event-based PrEP for the first time For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP) as an alternative to daily dosing. The International Antiviral Society-USA (IAS-USA) released its 2018 recommendations during the International AIDS Conference in Amsterdam, but there was […]

What is PEP?

Posted on by Health Reporter

Download PEP 101 Consumer Info Sheet PEP (post-exposure prophylaxis) means taking antiretroviral medicines (ART) after being potentially exposed to HIV to prevent becoming infected. PEP should be used only in emergency situations and must be started within 72 hours after a recent possible exposure to HIV. If you think you’ve recently been exposed to HIV […]

Posted in HIV

HIV may increase the risk of skin cancer

Posted on , updated on by Health Reporter

People living with HIV may have an increased risk of some types of skin cancer, Danish researchers report in the online edition of the Journal of the American Academy of Dermatology. The investigators compared the risk of basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and malignant melanoma (MM) between HIV-positive people enrolled in the […]

1600 people taking PrEP in Scotland and Wales, almost all are gay men

Posted on , updated on by Health Reporter

  “Welcome to a country where we do have a full NHS-delivered programme for PrEP, with no upper limit,” began Dr Rak Nandwani of NHS Glasgow and Clyde as he outlined Scotland’s experience to the joint conference of the British HIV Association (BHIVA) and British Association for Sexual Health and HIV (BASHH) in Edinburgh yesterday. […]